{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:07:16Z","timestamp":1781561236363,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hospital Program for Clinical Research"},{"name":"Association de l'Ost\u00e9ogen\u00e8se Imparfaite"},{"name":"Merck & Company"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.bone.2009.12.003","type":"journal-article","created":{"date-parts":[[2009,12,12]],"date-time":"2009-12-12T06:28:12Z","timestamp":1260599292000},"page":"897-900","source":"Crossref","is-referenced-by-count":17,"title":["Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations"],"prefix":"10.1016","volume":"46","author":[{"given":"Jean-Charles","family":"Rousseau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Chevrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Garnero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2009.12.003_bib1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.joca.2008.01.014","article-title":"Should subchondral bone turnover be targeted when treating osteoarthritis?","volume":"16","author":"Karsdal","year":"2008","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bone.2009.12.003_bib2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.joca.2005.03.008","article-title":"Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts","volume":"13","author":"Sanchez","year":"2005","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bone.2009.12.003_bib3","first-page":"349","article-title":"Biochemical and mechanical properties of subchondral bone in osteoarthritis","volume":"41","author":"Bailey","year":"2004","journal-title":"Biorheology"},{"issue":"12","key":"10.1016\/j.bone.2009.12.003_bib4","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1002\/art.10630","article-title":"Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study","volume":"46","author":"Bettica","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2009.12.003_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/ncprheum0508","article-title":"Biological markers in osteoarthritis","volume":"3","author":"Rousseau","year":"2007","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.bone.2009.12.003_bib6","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/art.23277","article-title":"A type I collagen defect leads to rapidly progressive osteoarthritis in a mouse model","volume":"58","author":"Blair-Levy","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2009.12.003_bib7","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00198-005-1905-5","article-title":"Musculoskeletal manifestations of mild osteogenesis imperfecta in the adult","volume":"16","author":"McKiernan","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2009.12.003_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1359\/JBMR.051015","article-title":"Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial","volume":"21","author":"Chevrel","year":"2006","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bone.2009.12.003_bib9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/art.20930","article-title":"collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis","volume":"52","author":"Charni","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2009.12.003_bib10","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/art.21366","article-title":"Bone marrow abnormality on magnetic resonance imaging is associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study","volume":"52","author":"Garnero","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2009.12.003_bib11","series-title":"Osteoporosis: Diagnosis and Management","first-page":"79","article-title":"Clinical usefulness of markers of bone remodelling in osteoporosis","author":"Garnero","year":"1998"},{"key":"10.1016\/j.bone.2009.12.003_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bone.2008.11.006","article-title":"Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations","volume":"44","author":"Garnero","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.12.003_bib13","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00198-009-0904-3","article-title":"Is bone quality associated with collagen age?","volume":"20","author":"Leeming","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2009.12.003_bib14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bone.2005.09.014","article-title":"Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone","volume":"38","author":"Garnero","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.12.003_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1471-2407-8-180","article-title":"Does increased local bone resorption secondary to breast and prostate cancer result in increased cartilage degradation?","volume":"8","author":"Leeming","year":"2008","journal-title":"BMC Cancer"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632820902095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632820902095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T12:56:04Z","timestamp":1544792164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632820902095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S875632820902095X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2009.12.003","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}